These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28139967)

  • 21. How Philip Morris unlocked the Japanese cigarette market: lessons for global tobacco control.
    Lambert A; Sargent JD; Glantz SA; Ling PM
    Tob Control; 2004 Dec; 13(4):379-87. PubMed ID: 15564622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyzing big tobacco's global youth marketing strategies and factors influencing smoking initiation by Nigeria youths using the theory of triadic influence.
    Isip U; Calvert J
    BMC Public Health; 2020 Mar; 20(1):377. PubMed ID: 32197659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The case for OFSMOKE: how tobacco price regulation is needed to promote the health of markets, government revenue and the public.
    Gilmore AB; Branston JR; Sweanor D
    Tob Control; 2010 Oct; 19(5):423-30. PubMed ID: 20876078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tobacco companies' use of developing countries' economic reliance on tobacco to lobby against global tobacco control: the case of Malawi.
    Otañez MG; Mamudu HM; Glantz SA
    Am J Public Health; 2009 Oct; 99(10):1759-71. PubMed ID: 19696392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Looming threat of Asian tobacco companies to global health.
    Lee K; Eckhardt J
    Lancet; 2017 May; 389(10083):1958-1960. PubMed ID: 28534742
    [No Abstract]   [Full Text] [Related]  

  • 26. Hungry for Hungary: examples of tobacco industry's expansionism.
    Szilágyi T; Chapman S
    Cent Eur J Public Health; 2003 Mar; 11(1):38-43. PubMed ID: 12690802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multi-level, multi-jurisdictional strategy: Transnational tobacco companies' attempts to obstruct tobacco packaging restrictions.
    Hawkins B; Holden C; Mackinder S
    Glob Public Health; 2019 Apr; 14(4):570-583. PubMed ID: 29521160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.
    Lee S; Ling PM; Glantz SA
    Cancer Causes Control; 2012 Mar; 23 Suppl 1(0 1):117-29. PubMed ID: 22370696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The strategic targeting of females by transnational tobacco companies in South Korea following trade liberalization.
    Lee K; Carpenter C; Challa C; Lee S; Connolly GN; Koh HK
    Global Health; 2009 Jan; 5():2. PubMed ID: 19183443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Globalisation of tobacco industry influence and new global responses.
    Yach D; Bettcher D
    Tob Control; 2000 Jun; 9(2):206-16. PubMed ID: 10841858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tobacco industry efforts to keep cigarettes affordable: a case study from Hungary.
    Szilágyi T; Chapman S
    Cent Eur J Public Health; 2003 Dec; 11(4):223-8. PubMed ID: 14768787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impacts of the Master Settlement Agreement on the tobacco industry.
    Sloan FA; Mathews CA; Trogdon JG
    Tob Control; 2004 Dec; 13(4):356-61. PubMed ID: 15564618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are marketing campaigns in Taiwan by foreign tobacco companies targeting young smokers?
    Wen CP; Chen T; Tsai YY; Tsai SP; Chung WS; Cheng TY; Levy DT; Hsu CC; Peterson R; Liu WY
    Tob Control; 2005 Jun; 14 Suppl 1(Suppl 1):i38-44. PubMed ID: 15923447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transnational tobacco companies and the mechanism of externalization: A realist synthesis.
    Mlinarić M; Schreuders M; Graen L; Lessenich S
    Health Place; 2020 Jan; 61():102240. PubMed ID: 31734138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us".
    Apollonio D; Glantz SA
    Am J Public Health; 2017 Oct; 107(10):1636-1642. PubMed ID: 28817320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smokeless Tobacco Supply Chain in South Asia: A Comparative Analysis Using the WHO Framework Convention on Tobacco Control.
    Siddiqi K; Scammell K; Huque R; Khan A; Baral S; Ali S; Watt I
    Nicotine Tob Res; 2016 Apr; 18(4):424-30. PubMed ID: 25795659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The globalization of tobacco use: 21 challenges for the 21st century.
    Glynn T; Seffrin JR; Brawley OW; Grey N; Ross H
    CA Cancer J Clin; 2010; 60(1):50-61. PubMed ID: 20097837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hidden dragons.
    Zeng M; Williamson PJ
    Harv Bus Rev; 2003 Oct; 81(10):92-9, 137. PubMed ID: 14521101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transnational tobacco company interests in smokeless tobacco in Europe: analysis of internal industry documents and contemporary industry materials.
    Peeters S; Gilmore AB
    PLoS Med; 2013; 10(9):e1001506. PubMed ID: 24058299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategic marketing in the UK tobacco industry.
    Anderson S; Hastings G; MacFadyen L
    Lancet Oncol; 2002 Aug; 3(8):481-6. PubMed ID: 12147434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.